PB0924 Venous Thromboembolism Risk in Lung Cancer Patients Receiving First-Line Immune Checkpoint Inhibitor Versus Chemotherapy

Autor: Li, A., May, S., La, J., Martens, K., Amos, C., Flowers, C., Do, N., Brophy, M., Chitalia, V., Ravid, K., Gaziano, J., Fillmore, N.
Zdroj: In Research and Practice in Thrombosis and Haemostasis October 2023 7 Supplement 2
Databáze: ScienceDirect